- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Kilitch Drugs (India) Ltd. has announced a board meeting to approve the financial results for the quarter ended 31st December 2024. Consequently, the trading window for all designated persons and their immediate relatives will be closed from 1st January 2025 until 48 hours after the results are disclosed. This closure is a standard practice intended to prevent insider trading around sensitive financial disclosures. Investors should monitor this period closely, as it may affect liquidity; however, the upcoming results could provide insights into the company’s performance and outlook, potentially influencing investor sentiment positively or negatively.